
Probing the Puzzle of Popliteal Pterygium Syndrome: The Role of Genetic Testing
Unlock early diagnosis of Popliteal Pterygium Syndrome with genetic testing. Explore personalized treatment and family planning options for managing this rare disorder.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock early diagnosis of Popliteal Pterygium Syndrome with genetic testing. Explore personalized treatment and family planning options for managing this rare disorder.

Genetic testing unveils porencephaly causes, aiding diagnosis, treatment, and research. Explore mutations, early detection, and personalized management strategies.

Explore how genetic testing identifies DNAH5 mutations, aiding in the accurate diagnosis and personalized management of primary ciliary dyskinesia symptoms.

Uncover PTEN Hamartoma Tumor Syndrome's genetic basis. Learn how genetic testing aids in early diagnosis, personalized treatment, and family risk assessment.

Explore how genetic testing helps diagnose renal tubular dysgenesis early, facilitating personalized treatment and informed family planning for better outcomes.

Explore how genetic testing transforms Rhabdoid Tumor Predisposition Syndrome (RTPS) management, from early diagnosis to personalized treatments and family risk assessment.

Genetic testing revolutionizes RGNT diagnosis and treatment by enhancing accuracy, guiding decisions, and offering prognostic insights to improve patient outcomes.

Explore genetic testing for Rothmund-Thomson Syndrome Type 1. Understand early diagnosis, family planning, surveillance, and personalized treatment strategies.